Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Ocrevus

Ocrelizumab

OcrelizumabCD20-directed Cytolytic Antibody [EPC]1 Variant

Clinical Data

Brand Name

Ocrevus

Generic Name

Ocrelizumab

Active Ingredient

Ocrelizumab

Drug Classes

CD20-directed Cytolytic Antibody [EPC]Endoglycosidase [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Ocrevus, you must consult a qualified healthcare professional.

Available Variants (1)

Different strengths and dosage forms

Strength	Form	Route	NDC
300 mg/10mL	INJECTION	INTRAVENOUS	50242-150